Valvular Heart Disease

The Valvular Heart Disease (VHD) Learning Pathway at ACC.23/WCC features sessions that will review current guideline-based recommendations and help clinicians learn to navigate controversies in everyday practice. Experts will address some of the key topics in VHD including hemodynamic assessment of valvular disease, emerging strategies for evaluating and managing tricuspid regurgitation (TR) and ethical dilemmas in VHD management.

Join in as experts highlight sex-related differences in epidemiology, pathophysiology and natural history of valve disease, as well as challenges regarding equitable enrollment in clinical trials (Session 755). Explore the controversies of VHD and the intersection with geriatric, ethics and resource utilization principles that apply to every interaction with patients being evaluated for VHD intervention (Session 726). In addition, tune in to understand the pathophysiology of functional TR, the strengths and limitation of current VHD guidelines, and advances in the management of TR (Session 767).

Take part in the VHD Learning Pathway for these exciting, informative sessions and more!

Additional Sessions You Won't Want to Miss:

  • The Most Fascinating Disease You'd Never Want to Have: Challenges in Contemporary Endocarditis Care (Session 620)
  • We Can, But Should We? Controversies in Treatment Options (Session 685)
  • Highlighted Original Research: Valvular Heart Disease and the Year in Review (Session 904)
American College of Cardiology

© 2022 American College of Cardiology Foundation. Visit

Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Cookie Policy Contact Us